Majority of cancer survivors report unmet needs in first year after treatment

the ONA take:

The majority of cancer survivors report one or more unmet needs in the first year after primary treatment, according to a new study published online ahead of print in the journal Psycho-oncology.

For the study, researchers enrolled 255 cancer survivors who were treated at one of eight Dutch hospitals between November 2012 and January 2013. All participants were surveyed about unmet needs, demographics, disease-related characteristics, and psychosocial characteristics.

Results showed that 63% of respondents reported one or more unmet needs. The most common unmet needs reported dealt with emotional support, smoking cessation, side effect/complication management, worries over recurrence, cancer care, social support, up-to-date information, and completing work.

Researchers found that age, higher education, support program participation, anxiety, depression, and negative adjustment style were associated with more unmet needs. On the other hand, female gender, time since last treatment, and quality of life correlated with fewer unmet needs.

CT scan not necessary to diagnose cancer in patients with unexplained blood clots
The majority of cancer survivors report one or more unmet needs in the first year after primary treatment.
To explore cancer survivors' unmet needs in the first year after primary treatment, and to investigate the relationship between demographic, disease-related, and psychosocial characteristics and the number of unmet needs in different domains.
READ FULL ARTICLE From Wiley Online Library
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs